Expression, but lack of calcium mobilization by high-affinity IgE Fcε receptor I on human epidermal and dermal Langerhans cells

Experimental Dermatology

Volumn 5, Issue 5, 1996, Pages 272-278

  Shibaki, A ^a,b   Ohkawara, A ^b   Shimada, S ^c   Ra, C ^d   Aiba, S ^e   Cooper, K D ^f  

^a UNIVERSITY OF MICHIGAN   (United States)

^b HOKKAIDO UNIVERSITY   (Japan)

^c UNIVERSITY OF YAMANASHI   (Japan)

^d JUNTENDO UNIVERSITY   (Japan)

^e TOHOKU UNIVERSITY   (Japan)

^f UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Calcium; Fc RI; Langerhans cells; Signal transduction

Indexed keywords

CELL RECEPTOR; IMMUNOGLOBULIN E;

ADULT; ARTICLE; ATOPIC DERMATITIS; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; LANGERHANS CELL; PHENOTYPE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VOLUNTEER;

EID: 0029811508     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0625.1996.tb00129.x     Document Type: Article

References (27)

1. Stingl G. Tamaki K, Katz S I. Origin and function of epidermal Langerhans cells. Immunol Rev 1980: 53: 150-174.
2. Stingl G. Katz S I, Clement L, Green L, Shevach E M. Immunologic functions of Ia-bearing epidermal Langerhans cells. J Immunol 1978: 121: 2005-2013.
3. Toews G B. Bergstresser P R, Streilein J W. Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J Immunol 1980: 124: 445-453.
4. + Langerhans cells are responsible for increased autologous T lymphocyte reactivity to lesional epidermal cells of patients with atopic dermatitis. J Immunol 1991: 147: 3794-3802.
5. Cooper K D. Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 1994: 102: 128-137.
6. Bruynzeel-Koomen C, Van Wichen D F. Toonstra J. Berrens L, Bruynzeel P L B. The presence of IgE molecules on epidermal Langerhans cells in patients with atopic dermatitis. Arch Dermatol Res 1986: 278: 199-205.
7. Wang B, Rieger A, Kilgus O et al. Epidermal Langerhans cells from normal human skin bind monomeric IgE via FcεRI. J Exp Med 1992: 175: 1353-1365.
8. Bieber T, De la Salle H, Wollenberg A et al. Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (FcεRI). J Exp Med 1992: 175: 1285-1290.
9. Jurgens M, Wollenberg A, Hanau D, De la Salle H. Bieber T. Activation of human epidermal Langerhans cells by engagement of the high affinity receptor for IgE, FcεRI. J Immunol 1995: 155: 5184-5189.
10. Tanaka Y, Tanaka M, Anan S, Yoshida H. Immunohistochemical studies on dust mite antigen in positive reaction site of patch tests. Acta Dermato-venereologica (suppl) 1989: 144: 93-96.
11. Maurer D, Fiebiger E, Reiniger B. Expression of functional high-affinity immunoglobulin E receptor (FcεRI) on monocytes of atopic individuals. J Exp Med 1994: 179: 745-750.
12. Paolini R. Jouvin M H. Kinet J P. Phosphorylation and dephosphorylation of the high-affinity receptor for immunoglobulin E immediately after receptor engagement and disengagement. Nature 1991: 353: 855-858.
13. Beaven M A, Metzger H. Signal transduction by Fc receptors: the FcεRI case. Immunol Today 1993: 14: 222-226.
14. + cells in human dermal cell suspensions: identification of a small subset responsible for potent dermal antigen-presenting cell activity with features analogous to Langerhans cells. J Immunol 1993: 151: 4067-4080.
15. Dezutter-Dambuyant C, Fauré M, Schmitt D, Laquoi C, Thivolet J. Simultaneous detection of T6 and HLA-DR antigen distinguishes 3-cell subpopulations in dispersed normal human epidermal cells. Immunol Lett 1984: 7: 203-207.
16. + epidermal cell. J Invest Dermatol 1985: 85: 546-552.
17. Tse Y. Cooper K D. Cutaneous dermal Ia+ cells are capable of initiating delayed type hypersensitivity responses. J Invest Dermatol 1990: 94: 267-272.
18. Takahashi K, Takata M, Suwaki T et al. New flow cytometric method for surface phenotyping basophils from peripheral blood. J Immunol Meth 1993: 162: 17-21.
19. Shibaki A, Meunier L, Ra C, Shimada S. Ohkawara A, Cooper K D. Differential responsiveness of Langerhans cell subsets of varying phenotypic states in normal human epidermis. J Invest Dermatol 1995: 104: 42-46.
20. Gonzalez-Ramos, A, Cooper, K D, Hammerberg C.-Identification of a human dermal macrophage population responsible for constitutive restraint of primary dermal fibroblast proliferation. J Invest Dermatol 1996: 106: 305-311.
21. Shibaki A, Ohkawara A, Cooper K D. Differential extracellular signaling via FcjR and FMLP in functionally distinct antigen-presenting cell subsets: ultraviolet-induced epidermal macrophages vs. Langerhans cells. J Invest Dermatol 1995: 105: 383-387.
22. Bieber T. IgE-binding molecules on human Langerhans cells. Acta Dermato-venereoogica 1992: 176: 54-57.
23. Triggiani M, Casolaro V, Genovese A, Spadaro G. Marone G. Heterogeneity of human FcεRI-bearing cells. Annals of Allergy 1993: 71: 133-138.
24. Benhamou M, Siraganian R P. Protein-tyrosine phosphorylation: an essential component of FcεRI signaling. Immunol Today 1992: 13: 195-197.
25. Hamawy M M, Mergenhagen S E, Siraganian R P. Cell adherence to fibronectin and aggregation of the high affinity immunoglobulin E receptor synergistically regulate tyrosine phosphorylation of 105-115-kDa proteins. J Biol Chem 1993: 268: 5227-5233.
26. Bieber T. Jurgens M, Wollenberg A, Sander E, Hanau D, De la Salle H. Characterization of the protein tyrosine phosphatase CD45 on human epidermal La ngerhans cells. Eur J Immunol 1995: 25: 317-321.
27. Clement L T. Isoforms of the CD45 co mmon leukocyte antigen family: markers for human T-cell differentiation. J Clin Immunol 1992: 12: 1-10.